Clinical Trials for Veristat

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Veristat

Clinical Trials (1)

NCT05335993
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
PHASE2Active, not recruiting
10 participants
Started: Jul 25, 2022 · Completed: Jul 30, 2025
7 conditions2 sponsors3 locations